Skip to content

Establishment Labs ESTA Interest coverage

Interest coverage at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
24.5×-1.7×
Globus Medical logo
Globus MedicalGMED
42.4×
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
-387.3×-388×
Stryker logo
StrykerSYK
-3.0×
Medtronic logo
MedtronicMDT
9.1×+0.9×
Boston Scientific logo
Boston ScientificBSX
10.6×+1.7×

Other financials

Income statement

See full
Revenue$59.9M+44.7%
Gross profit$42.3M+52.2%
Operating income-$6.5M+61.6%
Net income-$13.4M+35.4%
EPS (diluted)-$0.45+35.7%

Balance sheet

See full
Cash & equivalents$68.1M-1.6%
Total debt$252.7M+12.0%
Total equity$14.8M-61.7%
Total assets$351.0M+5.3%

Cash flow

See full
Operating cash flow-$4.3M+79.2%
CapEx$1.9M+146%
Free cash flow-$6.2M+71.3%

Valuation

See full
Market cap$2.56B+41.4%
Enterprise value$2.75B+38.7%
P/S11.2×+0.5×

Profitability

See full
Gross margin70.1%+3.7pp
Operating margin-12.4%-4.8pp
Net margin-19.1%-7.4pp
FCF margin-18.1%-6.6pp

Returns & leverage

See full
Return on equity-164%-17.8pp
Debt / equity17.1×+11.2×
Current ratio-0.4×

Where this comes from

Calculated from Establishment Labs’s reported figures.

Based on trailing twelve months.

The official record: Establishment Labs’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Establishment Labs's interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Establishment Labs's interest coverage?
Establishment Labs (ESTA) reported interest coverage of -1.1× in Q1 2026.
How has Establishment Labs's interest coverage changed year-over-year?
Establishment Labs's interest coverage increased by 58.6% year-over-year, from -2.6× to -1.1×.
What is the long-term trend for Establishment Labs's interest coverage?
Over 5 years (2020 to 2025), Establishment Labs's interest coverage has grown at a -12.3% compound annual growth rate (CAGR), from -3× to -1.5×.
What does interest coverage mean?
Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.